Remdesivir Entèmedyè CAS 1770840-43-1 4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine COVID-19
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | 4-Amino-7-yodopirrolo [2,1-f][1,2,4] triazin |
Sinonim | 7-Iodopyrrolo [2,1-f][1,2,4] triazin-4-amine;Remdesivir-004;Remdesivir enpurte 30 |
Nimewo CAS | 1770840-43-1 |
Nimewo CAT | RF-PI304 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C6H5IN4 |
Pwa molekilè | 260.04 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Limyè jòn poud mawon |
Enfrawouj Spectrum | Konfòm ak estrikti |
Pite | ≥98.0% (HPLC) |
Pèt sou siye | ≤0.50% |
Single enpurte | ≤0.50% |
Metal lou | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
4-Amino-7-iodopyrrolo [2,1-f][1,2,4]triazine (CAS 1770840-43-1) se yon entèmedyè nan Remdesivir (CAS 1809249-37-3).Remdesivir se yon konpoze antiviral ki itilize pou anpeche aksyon RNA polymerase.Remdesivir te orijinal envestige kòm yon tretman pou viris Ebola, men li gen potansyèl pou trete yon varyete de viris RNA.Aktivite li kont fanmi viris coronavirus (CoV), tankou SARS-CoV ak MERS-CoV, te dekri an 2017, epi yo te envestige li tou kòm yon tretman potansyèl pou enfeksyon SARS-CoV-2.